Viewing Study NCT06899802

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:37 AM
Ignite Modification Date: 2026-01-13 @ 5:59 PM
Study NCT ID: NCT06899802
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-01
First Post: 2025-03-06
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Phase 2 Trial in Healthy Adult Participants of the Recombinant MVA-BN-WEV Vaccine
Sponsor: Bavarian Nordic
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Encephalitis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None vaccine View
None equine encephalitis View
None healthy participants View
None phase 2 View